Sernova Corp. (TSE:SVA – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as C$0.14 and last traded at C$0.15, with a volume of 97650 shares changing hands. The stock had previously closed at C$0.16.
Sernova Stock Down 3.2%
The stock’s 50 day simple moving average is C$0.18 and its two-hundred day simple moving average is C$0.18. The firm has a market cap of C$49.30 million, a P/E ratio of -3.00 and a beta of 0.67. The company has a debt-to-equity ratio of -4.40, a current ratio of 0.32 and a quick ratio of 18.11.
Sernova Company Profile
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.
See Also
- Five stocks we like better than Sernova
- How to Use the MarketBeat Stock Screener
- Why Vertical Aerospace Stock Could Double After This Flight Test
- What Does Downgrade Mean in Investing?
- Amazon: Breakout Confirmed—Here’s Where It Could Go Next
- What is the S&P/TSX Index?
- AI Stocks Are Surging—But Volatility Could Be the Next Big Test
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
